Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.

Identifieur interne : 002A30 ( Ncbi/Checkpoint ); précédent : 002A29; suivant : 002A31

Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.

Auteurs : P David Charles [États-Unis] ; Chandler E. Gill ; Henry M. Taylor ; Michael S. Putman ; Caralee R. Blair ; Amanda G. Roberts ; Gregory D. Ayers ; Peter E. Konrad

Source :

RBID : pubmed:20131401

English descriptors

Abstract

Many adults with intellectual disabilities (ID) have spasticity, where increased muscle tone impairs activities of daily living (ADL) self-performance and care delivery. There are few reports of spasticity treatment for people with ID, and none of functionally meaningful outcomes. Our objective is to determine the effect of comprehensive spasticity management on ADL self-performance and care delivery. Baseline evaluation included repeated modified Ashworth and range of motion assessments, and timed and videotaped care task observations. Spasticity treatment was initiated immediately thereafter. Follow-up evaluation was conducted after spasticity management was optimized, one year after initiation. All individuals with spasticity at a single developmental center for whom treatment goals could be identified were included. Treatment was recommended by a neurologist from any accepted treatment for spasticity except oral medications, including botulinum neurotoxin A, intrathecal baclofen and orthopedic procedures. The main outcome measure is comparison of ease of videotaped care delivery, rated by direct caregivers blinded to participant treatment status. Spasticity treatment resulted in significant improvement across all outcome measures. Range of motion improved by 9 degrees (P = 0.005) and MAS by 0.4 (P = 0.022). Participants took 14% percent less time to complete tasks post-treatment (P = 0.01). Thirteen caregivers completed evaluations of 35 video pairs with an intra-class correlation of 0.9. After treatment, undergarment change (P = 0.031) and shirt change (P = 0.017) were rated easier, and all goals (P = 0.0006). Transfers trended toward improvement (P = 0.053). This study shows comprehensive spasticity management provides meaningful improvement in ADL care for patients with ID, which may improve quality of life and reduce caregiver burden.

DOI: 10.1002/mds.22995
PubMed: 20131401


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20131401

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.</title>
<author>
<name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P David" last="Charles">P David Charles</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2551, USA. david.charles@vanderbilt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2551</wicri:regionArea>
<wicri:noRegion>Tennessee 37232-2551</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E" last="Gill">Chandler E. Gill</name>
</author>
<author>
<name sortKey="Taylor, Henry M" sort="Taylor, Henry M" uniqKey="Taylor H" first="Henry M" last="Taylor">Henry M. Taylor</name>
</author>
<author>
<name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
</author>
<author>
<name sortKey="Blair, Caralee R" sort="Blair, Caralee R" uniqKey="Blair C" first="Caralee R" last="Blair">Caralee R. Blair</name>
</author>
<author>
<name sortKey="Roberts, Amanda G" sort="Roberts, Amanda G" uniqKey="Roberts A" first="Amanda G" last="Roberts">Amanda G. Roberts</name>
</author>
<author>
<name sortKey="Ayers, Gregory D" sort="Ayers, Gregory D" uniqKey="Ayers G" first="Gregory D" last="Ayers">Gregory D. Ayers</name>
</author>
<author>
<name sortKey="Konrad, Peter E" sort="Konrad, Peter E" uniqKey="Konrad P" first="Peter E" last="Konrad">Peter E. Konrad</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.22995</idno>
<idno type="RBID">pubmed:20131401</idno>
<idno type="pmid">20131401</idno>
<idno type="wicri:Area/PubMed/Corpus">001972</idno>
<idno type="wicri:Area/PubMed/Curation">001972</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001606</idno>
<idno type="wicri:Area/Ncbi/Merge">002A30</idno>
<idno type="wicri:Area/Ncbi/Curation">002A30</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002A30</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.</title>
<author>
<name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P David" last="Charles">P David Charles</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2551, USA. david.charles@vanderbilt.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2551</wicri:regionArea>
<wicri:noRegion>Tennessee 37232-2551</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E" last="Gill">Chandler E. Gill</name>
</author>
<author>
<name sortKey="Taylor, Henry M" sort="Taylor, Henry M" uniqKey="Taylor H" first="Henry M" last="Taylor">Henry M. Taylor</name>
</author>
<author>
<name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
</author>
<author>
<name sortKey="Blair, Caralee R" sort="Blair, Caralee R" uniqKey="Blair C" first="Caralee R" last="Blair">Caralee R. Blair</name>
</author>
<author>
<name sortKey="Roberts, Amanda G" sort="Roberts, Amanda G" uniqKey="Roberts A" first="Amanda G" last="Roberts">Amanda G. Roberts</name>
</author>
<author>
<name sortKey="Ayers, Gregory D" sort="Ayers, Gregory D" uniqKey="Ayers G" first="Gregory D" last="Ayers">Gregory D. Ayers</name>
</author>
<author>
<name sortKey="Konrad, Peter E" sort="Konrad, Peter E" uniqKey="Konrad P" first="Peter E" last="Konrad">Peter E. Konrad</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Activities of Daily Living</term>
<term>Adult</term>
<term>Aged</term>
<term>Baclofen (administration & dosage)</term>
<term>Baclofen (therapeutic use)</term>
<term>Botulinum Toxins, Type A (administration & dosage)</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Cerebral Palsy (drug therapy)</term>
<term>Cerebral Palsy (epidemiology)</term>
<term>Comorbidity</term>
<term>Epilepsy (epidemiology)</term>
<term>Female</term>
<term>Hemiplegia (drug therapy)</term>
<term>Hemiplegia (epidemiology)</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Injections, Spinal</term>
<term>Intellectual Disability (epidemiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle Relaxants, Central (administration & dosage)</term>
<term>Muscle Relaxants, Central (therapeutic use)</term>
<term>Muscle Spasticity (drug therapy)</term>
<term>Muscle Spasticity (epidemiology)</term>
<term>Neuromuscular Agents (administration & dosage)</term>
<term>Neuromuscular Agents (therapeutic use)</term>
<term>Prevalence</term>
<term>Videotape Recording</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Baclofen</term>
<term>Botulinum Toxins, Type A</term>
<term>Muscle Relaxants, Central</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Baclofen</term>
<term>Botulinum Toxins, Type A</term>
<term>Muscle Relaxants, Central</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Cerebral Palsy</term>
<term>Hemiplegia</term>
<term>Muscle Spasticity</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Cerebral Palsy</term>
<term>Epilepsy</term>
<term>Hemiplegia</term>
<term>Intellectual Disability</term>
<term>Muscle Spasticity</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Activities of Daily Living</term>
<term>Adult</term>
<term>Aged</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intramuscular</term>
<term>Injections, Spinal</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Videotape Recording</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Many adults with intellectual disabilities (ID) have spasticity, where increased muscle tone impairs activities of daily living (ADL) self-performance and care delivery. There are few reports of spasticity treatment for people with ID, and none of functionally meaningful outcomes. Our objective is to determine the effect of comprehensive spasticity management on ADL self-performance and care delivery. Baseline evaluation included repeated modified Ashworth and range of motion assessments, and timed and videotaped care task observations. Spasticity treatment was initiated immediately thereafter. Follow-up evaluation was conducted after spasticity management was optimized, one year after initiation. All individuals with spasticity at a single developmental center for whom treatment goals could be identified were included. Treatment was recommended by a neurologist from any accepted treatment for spasticity except oral medications, including botulinum neurotoxin A, intrathecal baclofen and orthopedic procedures. The main outcome measure is comparison of ease of videotaped care delivery, rated by direct caregivers blinded to participant treatment status. Spasticity treatment resulted in significant improvement across all outcome measures. Range of motion improved by 9 degrees (P = 0.005) and MAS by 0.4 (P = 0.022). Participants took 14% percent less time to complete tasks post-treatment (P = 0.01). Thirteen caregivers completed evaluations of 35 video pairs with an intra-class correlation of 0.9. After treatment, undergarment change (P = 0.031) and shirt change (P = 0.017) were rated easier, and all goals (P = 0.0006). Transfers trended toward improvement (P = 0.053). This study shows comprehensive spasticity management provides meaningful improvement in ADL care for patients with ID, which may improve quality of life and reduce caregiver burden.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Ayers, Gregory D" sort="Ayers, Gregory D" uniqKey="Ayers G" first="Gregory D" last="Ayers">Gregory D. Ayers</name>
<name sortKey="Blair, Caralee R" sort="Blair, Caralee R" uniqKey="Blair C" first="Caralee R" last="Blair">Caralee R. Blair</name>
<name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E" last="Gill">Chandler E. Gill</name>
<name sortKey="Konrad, Peter E" sort="Konrad, Peter E" uniqKey="Konrad P" first="Peter E" last="Konrad">Peter E. Konrad</name>
<name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
<name sortKey="Roberts, Amanda G" sort="Roberts, Amanda G" uniqKey="Roberts A" first="Amanda G" last="Roberts">Amanda G. Roberts</name>
<name sortKey="Taylor, Henry M" sort="Taylor, Henry M" uniqKey="Taylor H" first="Henry M" last="Taylor">Henry M. Taylor</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P David" last="Charles">P David Charles</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A30 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 002A30 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:20131401
   |texte=   Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:20131401" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024